[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Intravenous Injection General Anesthesia Drugs Market Research Report 2024(Status and Outlook)

June 2024 | 144 pages | ID: G377748B1A86EN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview:

Intravenous general anesthesia refers to a method in which one or several drugs are injected intravenously and act on the central nervous system through blood circulation to produce general anesthesia. According to different administration methods, intravenous anesthesia can be divided into single administration method, divided administration method and continuous administration method. Due to some limitations of its own, the use of intravenous general anesthesia was once limited. However, since the 1980s, with the continuous improvement of clinical pharmacology research methods, the development of new strong and short-acting intravenous anesthetics and the advent of computerized intravenous automatic drug delivery systems, intravenous anesthesia has been greatly improved. And development, has now become the mainstream general anesthesia solution.

The Global Intravenous Injection General Anesthesia Drugs Market Size was estimated at USD 1697.58 million in 2023 and is projected to reach USD 2449.23 million by 2029, exhibiting a CAGR of 6.30% during the forecast period.

This report provides a deep insight into the global Intravenous Injection General Anesthesia Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Intravenous Injection General Anesthesia Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Intravenous Injection General Anesthesia Drugs market in any manner.

Global Intravenous Injection General Anesthesia Drugs Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Aspen Pharma

Fresenius-Kabi

AbbVie

Baxter Healthcare

B.Braun

Maruishi

Piramal

Hikma Pharmaceuticals

AstraZeneca

Nhwa

Hengrui

Xi'an Libang

Yichang Humanwell

China National Medicines Guorui Pharmaceutical Co.,Ltd.

Maruishi

Lunan Pharmaceutical Group Corporation

Market Segmentation (by Type)

Propofol

Sevoflurane

Remifentanil

Etomidate

Isoflurane

Other

Market Segmentation (by Application)

Hopitals

Clinics

Others

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Intravenous Injection General Anesthesia Drugs Market
  • Overview of the regional outlook of the Intravenous Injection General Anesthesia Drugs Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Intravenous Injection General Anesthesia Drugs Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Intravenous Injection General Anesthesia Drugs
1.2 Key Market Segments
  1.2.1 Intravenous Injection General Anesthesia Drugs Segment by Type
  1.2.2 Intravenous Injection General Anesthesia Drugs Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 INTRAVENOUS INJECTION GENERAL ANESTHESIA DRUGS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Intravenous Injection General Anesthesia Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
  2.1.2 Global Intravenous Injection General Anesthesia Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 INTRAVENOUS INJECTION GENERAL ANESTHESIA DRUGS MARKET COMPETITIVE LANDSCAPE

3.1 Global Intravenous Injection General Anesthesia Drugs Sales by Manufacturers (2019-2024)
3.2 Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Intravenous Injection General Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Intravenous Injection General Anesthesia Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Intravenous Injection General Anesthesia Drugs Sales Sites, Area Served, Product Type
3.6 Intravenous Injection General Anesthesia Drugs Market Competitive Situation and Trends
  3.6.1 Intravenous Injection General Anesthesia Drugs Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Intravenous Injection General Anesthesia Drugs Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 INTRAVENOUS INJECTION GENERAL ANESTHESIA DRUGS INDUSTRY CHAIN ANALYSIS

4.1 Intravenous Injection General Anesthesia Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF INTRAVENOUS INJECTION GENERAL ANESTHESIA DRUGS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 INTRAVENOUS INJECTION GENERAL ANESTHESIA DRUGS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Type (2019-2024)
6.3 Global Intravenous Injection General Anesthesia Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Intravenous Injection General Anesthesia Drugs Price by Type (2019-2024)

7 INTRAVENOUS INJECTION GENERAL ANESTHESIA DRUGS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Intravenous Injection General Anesthesia Drugs Market Sales by Application (2019-2024)
7.3 Global Intravenous Injection General Anesthesia Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Intravenous Injection General Anesthesia Drugs Sales Growth Rate by Application (2019-2024)

8 INTRAVENOUS INJECTION GENERAL ANESTHESIA DRUGS MARKET SEGMENTATION BY REGION

8.1 Global Intravenous Injection General Anesthesia Drugs Sales by Region
  8.1.1 Global Intravenous Injection General Anesthesia Drugs Sales by Region
  8.1.2 Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Region
8.2 North America
  8.2.1 North America Intravenous Injection General Anesthesia Drugs Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Intravenous Injection General Anesthesia Drugs Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Intravenous Injection General Anesthesia Drugs Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Intravenous Injection General Anesthesia Drugs Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Aspen Pharma
  9.1.1 Aspen Pharma Intravenous Injection General Anesthesia Drugs Basic Information
  9.1.2 Aspen Pharma Intravenous Injection General Anesthesia Drugs Product Overview
  9.1.3 Aspen Pharma Intravenous Injection General Anesthesia Drugs Product Market Performance
  9.1.4 Aspen Pharma Business Overview
  9.1.5 Aspen Pharma Intravenous Injection General Anesthesia Drugs SWOT Analysis
  9.1.6 Aspen Pharma Recent Developments
9.2 Fresenius-Kabi
  9.2.1 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Basic Information
  9.2.2 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Product Overview
  9.2.3 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Product Market Performance
  9.2.4 Fresenius-Kabi Business Overview
  9.2.5 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs SWOT Analysis
  9.2.6 Fresenius-Kabi Recent Developments
9.3 AbbVie
  9.3.1 AbbVie Intravenous Injection General Anesthesia Drugs Basic Information
  9.3.2 AbbVie Intravenous Injection General Anesthesia Drugs Product Overview
  9.3.3 AbbVie Intravenous Injection General Anesthesia Drugs Product Market Performance
  9.3.4 AbbVie Intravenous Injection General Anesthesia Drugs SWOT Analysis
  9.3.5 AbbVie Business Overview
  9.3.6 AbbVie Recent Developments
9.4 Baxter Healthcare
  9.4.1 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Basic Information
  9.4.2 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Product Overview
  9.4.3 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Product Market Performance
  9.4.4 Baxter Healthcare Business Overview
  9.4.5 Baxter Healthcare Recent Developments
9.5 B.Braun
  9.5.1 B.Braun Intravenous Injection General Anesthesia Drugs Basic Information
  9.5.2 B.Braun Intravenous Injection General Anesthesia Drugs Product Overview
  9.5.3 B.Braun Intravenous Injection General Anesthesia Drugs Product Market Performance
  9.5.4 B.Braun Business Overview
  9.5.5 B.Braun Recent Developments
9.6 Maruishi
  9.6.1 Maruishi Intravenous Injection General Anesthesia Drugs Basic Information
  9.6.2 Maruishi Intravenous Injection General Anesthesia Drugs Product Overview
  9.6.3 Maruishi Intravenous Injection General Anesthesia Drugs Product Market Performance
  9.6.4 Maruishi Business Overview
  9.6.5 Maruishi Recent Developments
9.7 Piramal
  9.7.1 Piramal Intravenous Injection General Anesthesia Drugs Basic Information
  9.7.2 Piramal Intravenous Injection General Anesthesia Drugs Product Overview
  9.7.3 Piramal Intravenous Injection General Anesthesia Drugs Product Market Performance
  9.7.4 Piramal Business Overview
  9.7.5 Piramal Recent Developments
9.8 Hikma Pharmaceuticals
  9.8.1 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Basic Information
  9.8.2 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Product Overview
  9.8.3 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Product Market Performance
  9.8.4 Hikma Pharmaceuticals Business Overview
  9.8.5 Hikma Pharmaceuticals Recent Developments
9.9 AstraZeneca
  9.9.1 AstraZeneca Intravenous Injection General Anesthesia Drugs Basic Information
  9.9.2 AstraZeneca Intravenous Injection General Anesthesia Drugs Product Overview
  9.9.3 AstraZeneca Intravenous Injection General Anesthesia Drugs Product Market Performance
  9.9.4 AstraZeneca Business Overview
  9.9.5 AstraZeneca Recent Developments
9.10 Nhwa
  9.10.1 Nhwa Intravenous Injection General Anesthesia Drugs Basic Information
  9.10.2 Nhwa Intravenous Injection General Anesthesia Drugs Product Overview
  9.10.3 Nhwa Intravenous Injection General Anesthesia Drugs Product Market Performance
  9.10.4 Nhwa Business Overview
  9.10.5 Nhwa Recent Developments
9.11 Hengrui
  9.11.1 Hengrui Intravenous Injection General Anesthesia Drugs Basic Information
  9.11.2 Hengrui Intravenous Injection General Anesthesia Drugs Product Overview
  9.11.3 Hengrui Intravenous Injection General Anesthesia Drugs Product Market Performance
  9.11.4 Hengrui Business Overview
  9.11.5 Hengrui Recent Developments
9.12 Xi'an Libang
  9.12.1 Xi'an Libang Intravenous Injection General Anesthesia Drugs Basic Information
  9.12.2 Xi'an Libang Intravenous Injection General Anesthesia Drugs Product Overview
  9.12.3 Xi'an Libang Intravenous Injection General Anesthesia Drugs Product Market Performance
  9.12.4 Xi'an Libang Business Overview
  9.12.5 Xi'an Libang Recent Developments
9.13 Yichang Humanwell
  9.13.1 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Basic Information
  9.13.2 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Product Overview
  9.13.3 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Product Market Performance
  9.13.4 Yichang Humanwell Business Overview
  9.13.5 Yichang Humanwell Recent Developments
9.14 China National Medicines Guorui Pharmaceutical Co.,Ltd.
  9.14.1 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Basic Information
  9.14.2 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Product Overview
  9.14.3 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Product Market Performance
  9.14.4 China National Medicines Guorui Pharmaceutical Co.,Ltd. Business Overview
  9.14.5 China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Developments
9.15 Maruishi
  9.15.1 Maruishi Intravenous Injection General Anesthesia Drugs Basic Information
  9.15.2 Maruishi Intravenous Injection General Anesthesia Drugs Product Overview
  9.15.3 Maruishi Intravenous Injection General Anesthesia Drugs Product Market Performance
  9.15.4 Maruishi Business Overview
  9.15.5 Maruishi Recent Developments
9.16 Lunan Pharmaceutical Group Corporation
  9.16.1 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Basic Information
  9.16.2 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Product Overview
  9.16.3 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Product Market Performance
  9.16.4 Lunan Pharmaceutical Group Corporation Business Overview
  9.16.5 Lunan Pharmaceutical Group Corporation Recent Developments

10 INTRAVENOUS INJECTION GENERAL ANESTHESIA DRUGS MARKET FORECAST BY REGION

10.1 Global Intravenous Injection General Anesthesia Drugs Market Size Forecast
10.2 Global Intravenous Injection General Anesthesia Drugs Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Intravenous Injection General Anesthesia Drugs Market Size Forecast by Country
  10.2.3 Asia Pacific Intravenous Injection General Anesthesia Drugs Market Size Forecast by Region
  10.2.4 South America Intravenous Injection General Anesthesia Drugs Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Intravenous Injection General Anesthesia Drugs by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global Intravenous Injection General Anesthesia Drugs Market Forecast by Type (2025-2030)
  11.1.1 Global Forecasted Sales of Intravenous Injection General Anesthesia Drugs by Type (2025-2030)
  11.1.2 Global Intravenous Injection General Anesthesia Drugs Market Size Forecast by Type (2025-2030)
  11.1.3 Global Forecasted Price of Intravenous Injection General Anesthesia Drugs by Type (2025-2030)
11.2 Global Intravenous Injection General Anesthesia Drugs Market Forecast by Application (2025-2030)
  11.2.1 Global Intravenous Injection General Anesthesia Drugs Sales (Kilotons) Forecast by Application
  11.2.2 Global Intravenous Injection General Anesthesia Drugs Market Size (M USD) Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Intravenous Injection General Anesthesia Drugs Market Size Comparison by Region (M USD)
Table 5. Global Intravenous Injection General Anesthesia Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Intravenous Injection General Anesthesia Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Intravenous Injection General Anesthesia Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Injection General Anesthesia Drugs as of 2022)
Table 10. Global Market Intravenous Injection General Anesthesia Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Intravenous Injection General Anesthesia Drugs Sales Sites and Area Served
Table 12. Manufacturers Intravenous Injection General Anesthesia Drugs Product Type
Table 13. Global Intravenous Injection General Anesthesia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Intravenous Injection General Anesthesia Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Intravenous Injection General Anesthesia Drugs Market Challenges
Table 22. Global Intravenous Injection General Anesthesia Drugs Sales by Type (Kilotons)
Table 23. Global Intravenous Injection General Anesthesia Drugs Market Size by Type (M USD)
Table 24. Global Intravenous Injection General Anesthesia Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Intravenous Injection General Anesthesia Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Intravenous Injection General Anesthesia Drugs Market Size Share by Type (2019-2024)
Table 28. Global Intravenous Injection General Anesthesia Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Intravenous Injection General Anesthesia Drugs Sales (Kilotons) by Application
Table 30. Global Intravenous Injection General Anesthesia Drugs Market Size by Application
Table 31. Global Intravenous Injection General Anesthesia Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Intravenous Injection General Anesthesia Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Intravenous Injection General Anesthesia Drugs Market Share by Application (2019-2024)
Table 35. Global Intravenous Injection General Anesthesia Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Intravenous Injection General Anesthesia Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Intravenous Injection General Anesthesia Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Intravenous Injection General Anesthesia Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Intravenous Injection General Anesthesia Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Intravenous Injection General Anesthesia Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Aspen Pharma Intravenous Injection General Anesthesia Drugs Basic Information
Table 44. Aspen Pharma Intravenous Injection General Anesthesia Drugs Product Overview
Table 45. Aspen Pharma Intravenous Injection General Anesthesia Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Aspen Pharma Business Overview
Table 47. Aspen Pharma Intravenous Injection General Anesthesia Drugs SWOT Analysis
Table 48. Aspen Pharma Recent Developments
Table 49. Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Basic Information
Table 50. Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Product Overview
Table 51. Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Fresenius-Kabi Business Overview
Table 53. Fresenius-Kabi Intravenous Injection General Anesthesia Drugs SWOT Analysis
Table 54. Fresenius-Kabi Recent Developments
Table 55. AbbVie Intravenous Injection General Anesthesia Drugs Basic Information
Table 56. AbbVie Intravenous Injection General Anesthesia Drugs Product Overview
Table 57. AbbVie Intravenous Injection General Anesthesia Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. AbbVie Intravenous Injection General Anesthesia Drugs SWOT Analysis
Table 59. AbbVie Business Overview
Table 60. AbbVie Recent Developments
Table 61. Baxter Healthcare Intravenous Injection General Anesthesia Drugs Basic Information
Table 62. Baxter Healthcare Intravenous Injection General Anesthesia Drugs Product Overview
Table 63. Baxter Healthcare Intravenous Injection General Anesthesia Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Baxter Healthcare Business Overview
Table 65. Baxter Healthcare Recent Developments
Table 66. B.Braun Intravenous Injection General Anesthesia Drugs Basic Information
Table 67. B.Braun Intravenous Injection General Anesthesia Drugs Product Overview
Table 68. B.Braun Intravenous Injection General Anesthesia Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. B.Braun Business Overview
Table 70. B.Braun Recent Developments
Table 71. Maruishi Intravenous Injection General Anesthesia Drugs Basic Information
Table 72. Maruishi Intravenous Injection General Anesthesia Drugs Product Overview
Table 73. Maruishi Intravenous Injection General Anesthesia Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Maruishi Business Overview
Table 75. Maruishi Recent Developments
Table 76. Piramal Intravenous Injection General Anesthesia Drugs Basic Information
Table 77. Piramal Intravenous Injection General Anesthesia Drugs Product Overview
Table 78. Piramal Intravenous Injection General Anesthesia Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Piramal Business Overview
Table 80. Piramal Recent Developments
Table 81. Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Basic Information
Table 82. Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Product Overview
Table 83. Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Hikma Pharmaceuticals Business Overview
Table 85. Hikma Pharmaceuticals Recent Developments
Table 86. AstraZeneca Intravenous Injection General Anesthesia Drugs Basic Information
Table 87. AstraZeneca Intravenous Injection General Anesthesia Drugs Product Overview
Table 88. AstraZeneca Intravenous Injection General Anesthesia Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. AstraZeneca Business Overview
Table 90. AstraZeneca Recent Developments
Table 91. Nhwa Intravenous Injection General Anesthesia Drugs Basic Information
Table 92. Nhwa Intravenous Injection General Anesthesia Drugs Product Overview
Table 93. Nhwa Intravenous Injection General Anesthesia Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Nhwa Business Overview
Table 95. Nhwa Recent Developments
Table 96. Hengrui Intravenous Injection General Anesthesia Drugs Basic Information
Table 97. Hengrui Intravenous Injection General Anesthesia Drugs Product Overview
Table 98. Hengrui Intravenous Injection General Anesthesia Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Hengrui Business Overview
Table 100. Hengrui Recent Developments
Table 101. Xi'an Libang Intravenous Injection General Anesthesia Drugs Basic Information
Table 102. Xi'an Libang Intravenous Injection General Anesthesia Drugs Product Overview
Table 103. Xi'an Libang Intravenous Injection General Anesthesia Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Xi'an Libang Business Overview
Table 105. Xi'an Libang Recent Developments
Table 106. Yichang Humanwell Intravenous Injection General Anesthesia Drugs Basic Information
Table 107. Yichang Humanwell Intravenous Injection General Anesthesia Drugs Product Overview
Table 108. Yichang Humanwell Intravenous Injection General Anesthesia Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Yichang Humanwell Business Overview
Table 110. Yichang Humanwell Recent Developments
Table 111. China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Basic Information
Table 112. China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Product Overview
Table 113. China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. China National Medicines Guorui Pharmaceutical Co.,Ltd. Business Overview
Table 115. China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Developments
Table 116. Maruishi Intravenous Injection General Anesthesia Drugs Basic Information
Table 117. Maruishi Intravenous Injection General Anesthesia Drugs Product Overview
Table 118. Maruishi Intravenous Injection General Anesthesia Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Maruishi Business Overview
Table 120. Maruishi Recent Developments
Table 121. Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Basic Information
Table 122. Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Product Overview
Table 123. Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Lunan Pharmaceutical Group Corporation Business Overview
Table 125. Lunan Pharmaceutical Group Corporation Recent Developments
Table 126. Global Intravenous Injection General Anesthesia Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Intravenous Injection General Anesthesia Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Intravenous Injection General Anesthesia Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Intravenous Injection General Anesthesia Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Intravenous Injection General Anesthesia Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Intravenous Injection General Anesthesia Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Intravenous Injection General Anesthesia Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Intravenous Injection General Anesthesia Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Intravenous Injection General Anesthesia Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Intravenous Injection General Anesthesia Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Intravenous Injection General Anesthesia Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Intravenous Injection General Anesthesia Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Intravenous Injection General Anesthesia Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Intravenous Injection General Anesthesia Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Intravenous Injection General Anesthesia Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Intravenous Injection General Anesthesia Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Intravenous Injection General Anesthesia Drugs Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Intravenous Injection General Anesthesia Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Intravenous Injection General Anesthesia Drugs Market Size (M USD), 2019-2030
Figure 5. Global Intravenous Injection General Anesthesia Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Intravenous Injection General Anesthesia Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Intravenous Injection General Anesthesia Drugs Market Size by Country (M USD)
Figure 11. Intravenous Injection General Anesthesia Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Intravenous Injection General Anesthesia Drugs Revenue Share by Manufacturers in 2023
Figure 13. Intravenous Injection General Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Intravenous Injection General Anesthesia Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Intravenous Injection General Anesthesia Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Intravenous Injection General Anesthesia Drugs Market Share by Type
Figure 18. Sales Market Share of Intravenous Injection General Anesthesia Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Intravenous Injection General Anesthesia Drugs by Type in 2023
Figure 20. Market Size Share of Intravenous Injection General Anesthesia Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Intravenous Injection General Anesthesia Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Intravenous Injection General Anesthesia Drugs Market Share by Application
Figure 24. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Application in 2023
Figure 26. Global Intravenous Injection General Anesthesia Drugs Market Share by Application (2019-2024)
Figure 27. Global Intravenous Injection General Anesthesia Drugs Market Share by Application in 2023
Figure 28. Global Intravenous Injection General Anesthesia Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Intravenous Injection General Anesthesia Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Intravenous Injection General Anesthesia Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Intravenous Injection General Anesthesia Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Intravenous Injection General Anesthesia Drugs Sales Market Share by Country in 2023
Figure 37. Germany Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Intravenous Injection General Anesthesia Drugs Sales Market Share by Region in 2023
Figure 44. China Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Intravenous Injection General Anesthesia Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Intravenous Injection General Anesthesia Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Intravenous Injection General Anesthesia Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Intravenous Injection General Anesthesia Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Intravenous Injection General Anesthesia Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Intravenous Injection General Anesthesia Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Intravenous Injection General Anesthesia Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Intravenous Injection General Anesthesia Drugs Market Share Forecast by Application (2025-2030)


More Publications